Complete dosing information for risankizumab
Medical guidance required: Dosing information here is for educational purposes. Your healthcare provider will determine the appropriate dose based on your specific condition, kidney function, other medications, and medical history. Never adjust your dose without consulting your doctor or pharmacist.
Plaque psoriasis: 150 mg SC at weeks 0, 4, then every 12 weeks. PsA: 150 mg SC at weeks 0, 4, then every 12 weeks. Crohn's disease: 600 mg IV (3 doses at weeks 0, 4, 8 for induction), then 360 mg SC every 8 weeks for maintenance. Ulcerative colitis: 1200 mg IV (3 doses at weeks 0, 4, 8), then 180 mg SC every 8 weeks; 360 mg SC every 8 weeks for prior TNFi failure.
Not approved for pediatric use.
No dose adjustment required.
No dose adjustment required.